CIK 0001281895 · Non-accelerated filer<br>Smaller reporting company
ROCKET PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- RCKT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 646-440-9100
- Business address
- 350 FIFTH AVENUE, SUITE 7530, NEW YORK, NY, 10118
- Former names
- INOTEK PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $405,500
- in 5 filings
Net −$405,500. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-21 | Patel Kinnari See Remarks | Sale | −4,588 | $13.05 | $60K | 392,395 |
| 2024-11-21 | Shah Gaurav CEO | Sale | −11,091 | $13.05 | $145K | 707,328 |
| 2024-08-16 | Schwartz Jonathan David See Remarks | Sale | −2,710 | $18.50 | $50K | 166,949 |
| 2024-05-17 | Schwartz Jonathan David See Remarks | Sale | −2,754 | $23.35 | $64K | 169,659 |
Page 9 of 9 · 164 trades